Journals / Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi / 2016 / Cilt: 13 - Sayı: 4

The Effects of Body Mass Index on Fertility, Pregnancy and Delivery

Vücut Kitle İndeksinin Doğurganlık, Gebelik ve Doğum Üzerine Etkileri

Pages
170–175
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article aims to present a review of the recent scientific literature about the effects of BMI on fertility, pregnancy and delivery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity is a worldwide public health issue, associated with many chronic health issues.
📊
Key Findings & Data:There is increasing prevalence of overweight body mass index –BMI= 25.0-29.9 kg/m2 and obesity BMI ≥30.0 kg/m2 in young women, which impacts on fertility, pregnancy and delivery outcomes.
💡
Conclusion & Impact:This article aims to present a review of the recent scientific literature about the effects of BMI on fertility, pregnancy and delivery.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:VKİ · fertilite · gebelik

Abstract

Obesity is a worldwide public health issue, associated with many chronic health issues. There is increasing prevalence of overweight body mass index –BMI= 25.0-29.9 kg/m2 and obesity BMI ≥30.0 kg/m2 in young women, which impacts on fertility, pregnancy and delivery outcomes. Obesity and overweight also contribute to reduced male fecundity. Effects of obesity and overweight on successful in vitro fertilisation outcomes are less clear. Women with low BMI and/ or less-than-recommended gestational weight gain are at higher risk of delivering low birth weight babies. On the other hand, high BMI is linked with increased incidence of gestational hypertension, preeclampsia, induction of labour, macrosomia and caesarean delivery. This article aims to present a review of the recent scientific literature about the effects of BMI on fertility, pregnancy and delivery.

Özet

Obezite, beraberindeki birçok kronik sağlık sorunuyla birlikte tüm dünyada halk sağlığı sorunu olmuştur. Doğurganlık, gebelik ve doğum üzerinde etkileri olan aşırı kilo Vücut Kitle İndeksi-VKİ=25.0-29.9 kg/m2 ve obezitenin VKİ ≥30.0 kg/m2 genç kadınlar arasındaki yaygınlığında artış görülmektedir. Obezite ve aşırı kilo aynı zamanda erkek fekunditesinin düşmesine de sebep olmaktadır. Obezite ve aşırı kiloluluğun başarılı in vitro fertilizasyon üzerindeki etkilerine dair tam anlamıyla net sonuçlar bulunmamaktadır. Düşük VKİ’ye sahip ve/veya gebelikte önerilenden daha az kilo alan kadınların düşük doğum ağırlığına sahip bebek sahibi olma riski daha yüksektir. Diğer yandan, yüksek VKİ, artmış gestasyonel hipertansiyon, pre-eklampsi, doğum indüksiyonu, makrozomi ve sezaryenle doğum insidansı ile doğrudan ilişkilidir. Bu makalede VKİ’nin doğurganlık, gebelik ve doğum üzerine etkilerini güncel literatür bilgileri ışığında değerlendirmek amaçlanmıştır.

🔖

Cite This Article

KALEM, M. N., ESER, A., KAYGUSUZ, İ., CANBAL, M. (2022). The Effects of Body Mass Index on Fertility, Pregnancy and Delivery. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 13 - Sayı: 4, 170–175. https://ajindex.com/articles/558759

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35:93-9. Confidential Enquiry into Mother and Child Health (CEMACH). Why mo- thers die 2000-2002: The Sixth Report of the Confidential Enquiries into Maternal Death in the United Kingdom. London, UK: RCOG Press; 2004. World Health Organisation (WHO). Fact sheet 113: Obesity and overwe- ight. Geneva, Switzerland: WHO Press; [updated 2015 Jan]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  2. Dallongeville J, Bringer J, Bruckert E, Charbonnel B, Dievart F, Komajda M et al. Abdominal obesity is associated with ineffective control of car- diovascular risk factors in primary care in France. Diabetes Metab 2008; 34:606-11.
  3. Phillips LK, Prins JB. The link between abdominal obesity and the meta- bolic syndrome. Curr Hypertension Res; 10:156-64.
  4. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. Impa- ct of obesity on cardiovascular disease. Endocrin Metab Clin North Am 2008; 37:663-84.
  5. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414:782-7.
  6. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004; 23:6365-78.
  7. Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C. Knee os- teoarthritis and obesity. Int J Obes Relat Metab Disord 2001; 25:622-7.
  8. Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev 2001; 2:219-29.
  9. Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am 2005; 85:681-701.
  10. Suk Sh, Sacco Rl, Boden-Albala B, Cheun Jf, Pittman Jg, Elkind MS et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan stroke study. Stroke 2003; 34:1586-92. World Health Organisation (WHO). Physical status: the use and interp- retation of anthropometry: report of a WHO expert committee. Geneva, Switzerland: WHO Press; 1995. National Institutes of Health (NIH). Clinical guidelines on the identifica- tion, evaluation, and treatment of overweight and obesity in adults. The evidence report. NIH publication No. 98-4083. Bethesda US: NIH; 1998 National Institutes of Health (NIH). The practical guide. Identification, evaluation and treatment of overweight and obesity in adults. Bethesda US: NIH; 2000.
  11. Strohacker K, Wing RR, Mc Caffery JM. Contributions of body mass index and exercise habits on inflammatory markers: a cohort study of middle-aged adults living in the USA. BMJ Open 2013; 3:002623. Stejskal D, Karpisek M. Adipocyte fat